CHIMERIX INCCMRX

Market cap
$81.73M
P/E ratio
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Net income (loss)-36-59-117-76-71-69-113-44-173172-82
Depreciation00111110000
Amortization of debt issuance costs000------00
Amortization of discount/premium on investments-0-1-2-10120-127
Share-based compensation3413161613106121517
Fair value of common stock issued related to asset acquisition--------43--
Note payable related to asset acquisition--------14--
Gain on sale of TEMBEXA---------230-
Gain on sale of equipment----------0
Gain on sale of investments------0-0000-
Lease-related amortization--------00-0
Accounts receivable-1-02-10-11-1-01-1
Inventories--------32-
Prepaid expenses and other assets203-30-11-125-3
Accounts payable and accrued liabilities268-1030-4-076-2
Net cash used in operating activities-26-47-100-64-50-54-75-36-100-47-69
Net cash used in operating activities-26-47-100-64-50-54-75-36-100-47-69
Purchases of property and equipment01210000000
Purchases of short-term investments21556024-1261687410518390
Purchases of long-term investments-55235791636--105839
Proceeds from Sale of Short-Term Investments131-14111131748-
Proceeds from maturities of short-term investments11491271981661261651216769199
Proceeds from sale of TEMBEXA---------234-
Proceeds from sale of property and equipment-------0--0
Net cash provided by (used in) investing activities9-160-16994161051165-447071
Proceeds from Stock Options Exercised2520000141-
Proceeds from employee stock purchase plan-0101100110
Proceeds from Issuance of Common Stock--162--11--108--
Payments of deferred offering costs----000--0-
Payments of debt issuance costs----------0
Payment of note payable----------14-
Net cash provided by (used in) financing activities106225161111101112-130
Net increase (decrease) in cash and cash equivalents-------6430-32102
Non-cash purchases of property and equipment-------0---